Novo Integrated Sciences Board Conducts Review to Increase Stock Buyback Program -- Shares Soar

MT Newswires Live06-01

Novo Integrated Sciences (NVOS) said Friday that its board is conducting a strategic review to increase the maximum amount of its previously announced $5 million stock repurchase program.

The review aims to determine if it's appropriate to increase the buyback program based on the excess funds from a program to monetize standby letter of credit intended for the completion of Ophir Collection acquisition, Novo Integrated Sciences said.

Late Thursday, the company said HSBC issued a Ready, Willing and Able of a standby letter of credit, under which it is projected to get about $78 million in gross funding proceeds around June 14.

The company's shares soared 117% in recent trading.

Price: 0.98, Change: +0.53, Percent Change: +117.29

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment